Lazzeroni, M.
~ 700  Ergebnisse:
Personensuche X
?
2

SP-0858 Biologically-guided treatment - How to plan, delive..:

Lazzeroni, M.
Radiotherapy and Oncology.  182 (2023)  - p. S713-S714 , 2023
 
?
 
?
4

OC-0627 TCP predictions of an automated dose painting strat..:

Lazzeroni, M. ; Ureba, A. ; Nicolay, N.H....
Radiotherapy and Oncology.  170 (2022)  - p. S556-S557 , 2022
 
?
 
?
6

PO-1734 Automated treatment planning using dose mimicking f..:

Ureba, A. ; Öden, J. ; Toma-Dasu, I..
Radiotherapy and Oncology.  170 (2022)  - p. S1536-S1537 , 2022
 
?
7

PH-0217 Synergistic use of combined FDG and FMISO PET/CT im..:

Lazzeroni, M. ; Ureba, A. ; Nicolay, N.H....
Radiotherapy and Oncology.  161 (2021)  - p. S149-S151 , 2021
 
?
8

PO-1795 diffusion model based target definition for high-gr..:

Häger, W. ; Lazzeroni, M. ; Astaraki, M..
Radiotherapy and Oncology.  161 (2021)  - p. S1520-S1522 , 2021
 
?
9

Quantification of Tumor Oxygenation Based on FMISO PET: Inf..:

, In: Advances in Experimental Medicine and Biology; Oxygen Transport to Tissue XLI,
Lazzeroni, M. ; Toma-Dasu, I. ; Ureba, A.... - p. 177-182 , 2020
 
?
 
?
 
?
12

The risk of extra-ovarian malignancies among women with end..:

Gandini, S. ; Lazzeroni, M. ; Peccatori, F.A....
Critical Reviews in Oncology/Hematology.  134 (2019)  - p. 72-81 , 2019
 
?
13

OC-0406 Early survival prediction in non-small cell lung ca..:

Astaraki, M. ; Wang, C. ; Buizza, G....
Radiotherapy and Oncology.  133 (2019)  - p. S208-S209 , 2019
 
?
 
1-15